Evaluation of the Phased Radio Frequency Ablation System (VICTORY-AF)
Evaluation of Multielectrode Phased RF Technology in Persistent Atrial Fibrillation
Sponsor: Medtronic Cardiac Ablation Solutions
Terminated
The study was stopped solely based on lower than expected enrollment rate.
Other terminated trials from Medtronic Cardiac Ablation Solutions
See all terminations from Medtronic Cardiac Ablation Solutions
Other Persistent Atrial Fibrillation trials with similar outcome
A NA clinical study on Persistent Atrial Fibrillation, this trial is terminated or withdrawn. The trial is conducted by Medtronic Cardiac Ablation Solutions and has accumulated 13 data snapshots since 2013. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.
Status Flow
Change History
13 versions recorded-
Sep 2025 — Present [monthly]
Terminated NA
-
Mar 2025 — Sep 2025 [monthly]
Terminated NA
-
Sep 2024 — Mar 2025 [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Dec 2021 — Jul 2024 [monthly]
Terminated NA
▶ Show 8 earlier versions
-
Jan 2021 — Dec 2021 [monthly]
Terminated NA
-
Oct 2018 — Jan 2021 [monthly]
Terminated NA
-
Jun 2018 — Oct 2018 [monthly]
Terminated NA
-
Apr 2018 — Jun 2018 [monthly]
Terminated NA
-
Jan 2018 — Apr 2018 [monthly]
Terminated NA
-
Apr 2017 — Jan 2018 [monthly]
Terminated NA
Status: Active Not Recruiting → Terminated · Phase: PHASE3 → NA
-
Feb 2017 — Apr 2017 [monthly]
Active Not Recruiting PHASE3
-
Jan 2017 — Feb 2017 [monthly]
Active Not Recruiting PHASE3
First recorded
Nov 2013
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Medtronic Cardiac Ablation Solutions
For direct contact, visit the study record on ClinicalTrials.gov .